
Long-Term Results of the ILLUMINATE-A Trial of Lumasiran for Primary Hyperoxaluria Type 1
0:00
3:54
Dr. Saland summarizes the main findings from his study on "Final Results of the ILLUMINATE-A Phase 3 Clinical Trial of Lumasiran for Primary Hyperoxaluria 1.
Flere episoder fra "Clinical Journal of the American Society of Nephrology (CJASN)"



Gå ikke glip af nogen episoder af “Clinical Journal of the American Society of Nephrology (CJASN)” - abonnér på podcasten med gratisapp GetPodcast.








